Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

  • US 9,789,125 B2
  • Filed: 06/02/2016
  • Issued: 10/17/2017
  • Est. Priority Date: 07/09/2007
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising a Form α

  • crystal of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, wherein the Form α

    crystal is characterized by a powder X-ray diffraction pattern having any three or more powder X-ray diffraction peaks selected from the group consisting of powder X-ray diffraction peaks at about 10.2±

    0.3, 11.3±

    0.3, 11.8±

    0.3, 14.0±

    0.3, 14.3±

    0.3, 14.7±

    0.3, 16.1±

    0.3, and 18.3±

    0.3 degrees 2-theta.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×